BioEximi OÜ
Active Registry code 11767227
OÜ Tallinn Registered 19 Nov 2009
BioEximi OÜ is a OÜ based in Tallinn, registry code 11767227, status: active. Main activity: Other human health activities n.e.c.. According to EMTA, turnover for Q3 2026 was €74 439 with 38 employees.
Turnover
74 439 €
↑ 2.0% vs Q2 2026
State taxes
113 703 €
↑ 1.9% vs Q2 2026
Labour taxes
104 405 €
↑ 2.3% vs Q2 2026
Employees
38
+2 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 74 439 €above 90% of companiesindustry median 9 428 € · companies in the industry: 351
- Labour taxes per employee 2 748 €above 59% of companiesindustry median 2 177 € · companies in the industry: 1 696
- Revenue · 2025 2.2 mn €above 98% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 -1.7 %above 22% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 74 439 | 113 703 | 104 405 | 38 |
| Q2 2026 | 73 010 | 111 604 | 102 084 | 36 |
| Q1 2026 | 76 287 | 105 024 | 93 477 | 35 |
| Q4 2025 | 105 919 | 122 730 | 105 118 | 36 |
| Q3 2025 | 74 595 | 113 835 | 104 034 | 33 |
| Q2 2025 | 68 172 | 106 107 | 98 202 | 34 |
| Q1 2025 | 64 338 | 102 000 | 94 620 | 34 |
| Q4 2024 | 52 256 | 91 530 | 85 750 | 38 |
| Q3 2024 | 32 866 | 89 460 | 88 184 | 35 |
| Q2 2024 | 76 562 | 91 975 | 80 190 | 35 |
| Q1 2024 | 49 175 | 86 147 | 80 731 | 31 |
| Q4 2023 | 33 297 | 67 616 | 65 064 | 32 |
| Q3 2023 | 29 987 | 69 903 | 68 039 | 29 |
| Q2 2023 | 52 197 | 84 070 | 79 158 | 27 |
| Q1 2023 | 42 113 | 70 886 | 66 009 | 28 |
| Q4 2022 | 22 971 | 60 082 | 58 805 | 29 |
| Q3 2022 | 22 896 | 59 620 | 58 281 | 27 |
| Q2 2022 | 61 851 | 58 531 | 49 147 | 27 |
| Q1 2022 | 6 690 | 47 671 | 48 798 | 26 |
Labour taxes per employee per month
916 €
Turnover per employee in the quarter
1 959 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 2 176 753 | -36 732 | 875 855 | 553 948 | -34 097 | 18 |
| 2024 | 1 985 004 | -44 338 | 791 109 | 558 996 | -67 364 | 17 |
| 2023 | 1 601 558 | -146 151 | 627 124 | 495 800 | -144 676 | 13 |
| 2022 | 1 255 148 | -237 246 | 556 688 | 462 474 | -54 525 | 13 |
| 2021 | 1 054 278 | -121 422 | 373 028 | 376 402 | -242 279 | 13 |
| 2020 | 683 161 | 30 099 | 297 144 | 1 106 405 | 787 199 | 11 |
| 2019 | 619 909 | 223 560 | 203 244 | 829 080 | 757 100 | 13 |
| 2018 | — | — | — | — | — | 10 |
| 2017 | — | — | — | — | — | 9 |
| 2016 | — | — | — | — | — | 8 |
| 2015 | — | — | — | — | — | 6 |
| 2014 | — | — | — | — | — | 7 |
| 2013 | — | — | — | — | — | 9 |
| 2012 | — | — | — | — | — | 6 |
| 2011 | — | — | — | — | — | 5 |
| 2010 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-1.7 %
Net profit / revenue
Return on assets (ROA)
-6.6 %
Net profit / assets
Equity ratio
-6.2 %
Equity / assets
Debt ratio
106.2 %
Liabilities / assets
Current ratio
0.79
Current assets / current liabilities
Revenue per employee
120 931 €
Revenue / average full-time employees
Labour cost per employee per month
4 055 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 1 Jul 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 28 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 21 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 30 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 26 May 2020 | Company’s own | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 1 | 97 500 € | AS SEB Pank | 6 Sep 2021 – in force |
Board
- Miroslaw HerdenBoard member · since 11 Apr 2019
- Karin RosensteinBoard member · since 16 Mar 2020
- Nasdaq CSD SEKeeper of the share register · since 28 Sep 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Omanikukonto: NEXTCLINICS ESTONIA OÜLegal person · 14674334 · 2 560 €
Beneficial owners
- Miroslaw HerdenMember of a senior management body (management or supervisory board) · since 30 Jun 2021
- Karin RosensteinMember of a senior management body (management or supervisory board) · since 29 Jun 2021
Founders and other persons
- Jüri LaasikFounder · 40 000 € · 19 Nov 2009
Related companies
Activities (EMTAK)
- 86992Other human health activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10137083 / 23 20 Oct 2025 |
Amendment entry | In force 20 Oct 2025 |
||
| Ä 10137083 / 22 9 Jun 2023 |
Amendment entry | In force 9 Jun 2023 |
||
| Ä 10137083 / 21 9 Jun 2022 |
Amendment entry | In force 9 Jun 2022 |
||
| Ä 10137083 / 20 6 Sep 2021 |
Second (constitutive) merger entry | In force 6 Sep 2021 |
||
| K 10137083 / 19 6 Sep 2021 |
Commercial pledge entered | In force 6 Sep 2021 |
||
| Ä 10137083 / M6 14 Jul 2021 |
Ruling to eliminate deficiencies | 13 Aug 2021 | Deficiencies eliminated 6 Sep 2021 |
|
| Ä 10137083 / M5 5 Jul 2021 |
Procedural ruling | In force 5 Jul 2021 |
||
| Ä 10137083 / 18 14 Oct 2020 |
Amendment under Commercial Code § 525 (2) | In force 14 Oct 2020 |
||
| Ä 10137083 / 17 16 Mar 2020 |
Amendment entry | In force 16 Mar 2020 |
||
| Ä 10137083 / 16 26 Nov 2019 |
Second (constitutive) merger entry | In force 26 Nov 2019 |
||
| Ä 10137083 / 15 11 Apr 2019 |
Amendment entry | In force 11 Apr 2019 |
||
| Ä 10137083 / 14 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10137083 / 13 1 Dec 2017 |
Amendment entry | In force 1 Dec 2017 |
||
| Ä 10137083 / 12 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 10137083 / 11 13 Jul 2017 |
Amendment entry | In force 13 Jul 2017 |
||
| Ä 10137083 / 10 16 Sep 2016 |
Amendment entry | In force 16 Sep 2016 |
||
| Ä 10137083 / 9 9 Jul 2014 |
Amendment entry | In force 9 Jul 2014 |
||
| Ä 10137083 / 8 19 Oct 2013 |
Entry refused: deficiencies not eliminated | In force 14 Nov 2013 |
||
| Ä 10137083 / M4 27 Sep 2013 |
Ruling to eliminate deficiencies | 17 Oct 2013 | In force 27 Sep 2013 |
|
| Ä 10137083 / 7 21 Nov 2011 |
Amendment entry | In force 21 Nov 2011 |
||
| Ä 10137083 / M3 31 Oct 2011 |
Ruling to eliminate deficiencies | 25 Nov 2011 | Deficiencies eliminated 17 Nov 2011 |
|
| Ä 10137083 / 6 3 Feb 2011 |
Amendment entry | In force 3 Feb 2011 |
||
| Ä 10137083 / 5 25 Jan 2011 |
Amendment under Commercial Code § 525 (2) | In force 25 Jan 2011 |
||
| Ä 10137083 / M2 21 Jan 2011 |
Public service of a ruling in Ametlikud Teadaanded | In force 2 Jan 2013 |
||
| Ä 10137083 / 4 21 Dec 2010 |
Entry refused: deficiencies not eliminated | In force 10 Mar 2011 |
||
| Ä 10137083 / M1 16 Nov 2010 |
Ruling to eliminate deficiencies | In force 16 Nov 2010 |
||
| Ä 10137083 / 3 5 Jul 2010 |
Amendment entry | In force 5 Jul 2010 |
||
| Ä 10137083 / 2 29 Jun 2010 |
Note on registration of shares in the Estonian central register of securities | In force 29 Jun 2010 |
||
| Ä 137083 19 Nov 2009 |
First entry | In force 19 Nov 2009 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data